

HY-130149 · 10 mM * 1 mL in DMSO
MedChemExpress · Cat: HY-130149
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/mrtx849.html
Description
Adagrasib MRTX849 is a potent, orally-available, and mutation-selective covalent inhibitor of KRAS G12C with potential antineoplastic activity. Adagrasib covalently binds to KRAS G12C at the cysteine at residue 12, locks the protein in its inactive GDP-bound conformation, and inhibits KRAS-dependent signal transduction.







